Holen Sie sich die Stockscreener-App
2.00
3.38%
-0.07
Handel nachbörslich:
2.02
0.02
+1.00%
Schlusskurs vom Vortag:
$2.07
Offen:
$2.07
24-Stunden-Volumen:
553.35K
Relative Volume:
1.83
Marktkapitalisierung:
$33.35M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-9.70M
KGV:
-1.8182
EPS:
-1.1
Netto-Cashflow:
$-8.57M
1W Leistung:
+29.87%
1M Leistung:
+34.23%
6M Leistung:
+10.50%
1J Leistung:
-30.07%
1-Tages-Spanne:
$2.00
$2.29
1-Wochen-Bereich:
$1.59
$2.46
52-Wochen-Spanne:
$0.8099
$4.07
Marker Therapeutics Inc Stock (MRKR) Company Profile
Firmenname
Marker Therapeutics Inc
Sektor
Branche
Telefon
(713) 400-6400
Adresse
2450 HOLCOMBE BLVD, HOUSTON, TX
Vergleichen Sie MRKR mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRKR
Marker Therapeutics Inc
|
2.00 | 34.51M | 0 | -9.70M | -8.57M | -1.10 |
|
VRTX
Vertex Pharmaceuticals Inc
|
463.86 | 119.17B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
796.55 | 84.19B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
398.29 | 52.77B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
788.49 | 48.98B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
175.97 | 36.31B | 447.02M | -1.18B | -906.14M | -6.1812 |
Marker Therapeutics Inc Stock (MRKR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-05 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-03-25 | Eingeleitet | Piper Sandler | Overweight |
| 2021-03-19 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-05-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2019-05-30 | Eingeleitet | ROTH Capital | Buy |
| 2019-03-01 | Eingeleitet | Janney | Buy |
| 2018-12-03 | Hochstufung | Piper Jaffray | Neutral → Overweight |
Alle ansehen
Marker Therapeutics Inc Aktie (MRKR) Neueste Nachrichten
Will Marker Therapeutics Inc. stock benefit from green energy trendsSell Signal & Real-Time Chart Pattern Alerts - ulpravda.ru
How strong is Marker Therapeutics Inc. stock balance sheetWeekly Risk Report & Stepwise Entry and Exit Trade Signals - ulpravda.ru
Can Marker Therapeutics Inc. stock sustain market leadership2025 Investor Takeaways & AI Powered Buy/Sell Recommendations - ulpravda.ru
Why Marker Therapeutics Inc. (GX1) stock could rally stronglyDay Trade & Verified High Yield Trade Plans - ulpravda.ru
Will Marker Therapeutics Inc. stock benefit from commodity pricesTrade Volume Report & Free Community Consensus Stock Picks - ulpravda.ru
Why Marker Therapeutics Inc. stock remains on buy listsJuly 2025 Earnings & Fast Exit and Entry Trade Guides - ulpravda.ru
How sustainable is Marker Therapeutics Inc. stock dividend payoutPortfolio Value Summary & Stepwise Trade Signal Implementation - ulpravda.ru
Zacks Industry Outlook Highlights Soleno Therapeutics, Nektar Therapeutics, Rigel Pharmaceuticals, Ironwood Pharmaceuticals and Marker Therapeutics - Yahoo Finance
Marker Therapeutics, Inc. (MRKR) now trades above golden cross: Time to buy? - MSN
MARKER THERAPEUTICS, INC. (MRKR) Now Trades Above Golden Cross: Time to Buy? - Yahoo Finance
Marker Therapeutics stock maintains Buy rating at H.C. Wainwright By Investing.com - Investing.com UK
Is Marker Therapeutics Inc GX1 a good long term investmentMarket Sentiment Shifts & Buy Sell Signal Notifications - Early Times
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Brookline Capital raises Marker Therapeutics stock price target to $5.60 By Investing.com - Investing.com Canada
Marker Therapeutics Reports Positive Phase 1/2 Clinical Study Results for Multi-Antigen Targeted T Cells in Pancreatic Cancer Patients - Quiver Quantitative
Baylor College of Medicine Publishes Promising Safety and Efficacy Results of Multi-Antigen Targeted T Cells in Patients with Pancreatic Cancer - The Manila Times
Wall Street Zen Upgrades Marker Therapeutics (NASDAQ:MRKR) to Hold - Defense World
MRKR stock touches 52-week low at $1.8 amid market challenges - MSN
Why Marker Therapeutics Inc stock remains undervaluedMarket Trend Review & Verified Stock Trade Ideas - moha.gov.vn
Trade Recap: How Marker Therapeutics Inc GX1 stock reacts to monetary easing2025 Major Catalysts & Smart Investment Allocation Tips - moha.gov.vn
Nasdaq Moves: Is Mineralys Therapeutics Inc stock a safe investment in uncertain marketsJuly 2025 Outlook & Real-Time Volume Spike Alerts - moha.gov.vn
MRKR stock touches 52-week low at $2.4 amid challenging year - MSN
Technical Analysis: Amber Enterprises India Limited (AMBER)Stock Correlation Metrics & Superior Return Stocks - bollywoodhelpline.com
Moving Average Crossover Confirms Uptrend in Dharani Sugars and Chemicals LimitedEnergy Sector Updates & Interactive Charts for Smarter Trading - bollywoodhelpline.com
Profit Review: Will Marker Therapeutics Inc stock deliver shareholder valueWeekly Market Summary & Precise Entry and Exit Recommendations - moha.gov.vn
Fed Watch: Can Marker Therapeutics Inc stock deliver 10 annual returnsQuarterly Profit Report & Fast Gaining Stock Reports - moha.gov.vn
Can Prabhu Steel Industries Limited Bounce Back From Weekly LowFundamental Stock Analysis & Low Cost Trading Tips - bollywoodhelpline.com
Svam Software Limited Approaches Psychological Resistance LevelEconomic Impact on Stocks & Free Quantitative Trading Strategies - Bollywood Helpline
Sentiment Review: Will Marker Therapeutics Inc. stock benefit from green energy trendsPrice Action & Consistent Income Trade Ideas - moha.gov.vn
Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Key Lessons & Capital Efficiency Focused Ideas - Улправда
What insider trading reveals about Marker Therapeutics Inc. stockRisk Management & Real-Time Stock Price Movement Reports - Улправда
Risk Report: Can Marker Therapeutics Inc. stock withstand economic slowdown2025 Support & Resistance & Precise Swing Trade Alerts - Улправда
Risk Hedge: What insider trading reveals about Marker Therapeutics Inc. stockQuarterly Earnings Report & Proven Capital Preservation Tips - Улправда
Will Marker Therapeutics Inc. stock deliver shareholder valueJuly 2025 Weekly Recap & High Conviction Trade Alerts - DonanımHaber
Marker Therapeutics Earnings Notes - Trefis
Is Marker Therapeutics Inc. stock trading near support levelsJuly 2025 Levels & Fast Entry and Exit Trade Plans - Улправда
Retail Surge: Can Marker Therapeutics Inc. stock surprise with earnings upside2025 Volatility Report & High Accuracy Swing Trade Signals - ulpravda.ru
After-Hours Biotech Rally: Inspira, MediciNova, DiaMedica Therapeutics Among Gainers - RTTNews
How Marker Therapeutics Inc. (GX1) stock reacts to new regulationsJuly 2025 Earnings & Low Volatility Stock Recommendations - Улправда
Here's Why Marker Therapeutics (NASDAQ:MRKR) Must Use Its Cash Wisely - Yahoo Finance
US High Growth Tech Stocks To Watch December 2025 - simplywall.st
Marker Therapeutics, Inc. (NASDAQ:MRKR) Receives Consensus Rating of “Buy” from Analysts - Defense World
How strong is Marker Therapeutics Inc stock balance sheet2025 Top Decliners & Weekly High Return Opportunities - moha.gov.vn
Panic Selling: Is Marker Therapeutics Inc stock supported by strong cash flows2025 Pullback Review & Reliable Momentum Entry Alerts - moha.gov.vn
Published on: 2025-12-13 20:42:44 - moha.gov.vn
What drives Marker Therapeutics Inc GX1 stock priceDividend Stability Analysis & Consistent Triple Returns - earlytimes.in
FY2025 Earnings Forecast for MRKR Issued By HC Wainwright - Defense World
Marker Therapeutics (NASDAQ:MRKR) Coverage Initiated at HC Wainwright - Defense World
H.C. Wainwright reiterates Buy rating on Marker Therapeutics stock By Investing.com - Investing.com Canada
HC Wainwright & Co. Initiates Coverage of Marker Therapeutics (MRKR) with Buy Recommendation - Nasdaq
MRKR: HC Wainwright & Co. Initiates Coverage with a 'Buy' Rating - GuruFocus
Finanzdaten der Marker Therapeutics Inc-Aktie (MRKR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.90%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):